CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification

Reference

• BIGSBY, R., CHAPIN, R. E., DASTON, G. P., DAVIS, B. J., GORSKI., J., GRAY, L. E., HOWDESHELL, K. L., ZOELLER, R. T. and vom SL, F. S., 1999, Evaluating the effects of endocrine disruptors on endocrine function during development. Environmental Health Perspectives, 107\(Suppl. 4), 613–618.
   PubMedGoogle Scholar
• BLIZARD, D., SUEYOSHI, T., NEGISHI, M., DEHAL, S. S. and KUPFER, D., 2001, Mechanism of induction of cytochrome P450 enzymes by the proestrogenic endocrine disruptor pesticide methoxychlor: interactions of methoxychlor metabolites with the constitutive androstane receptor system. Drug Metabolism and Disposition, 29, 781–785.
   PubMed Web of Science ®Google Scholar
• BULGER, W. H., FEIL, V. J. and KUPFER, D., 1985, Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants. Molecular Pharmacology, 27, 115–124.
   PubMed Web of Science ®Google Scholar
• BULGER, W. H., MUCCITELLI, R. M. and KUPFER, D., 1978a, Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis-(p-hydroxy phenyl)-1,1,1-trichloroethane with rat uterine estrogen receptor. Journal of Toxicology and Environmental Health, 4, 881–893.
   PubMed Web of Science ®Google Scholar
• BULGER, W. H., MUCCITELLI, R. M. and KUPFER, D., 1978b, Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenases in methoxychlor activation. Biochemical Pharmacology, 27, 2417–2423.
   PubMed Web of Science ®Google Scholar
• CHAPIN, R. E., HARRIS, M. W., DAVIS, B. J., WARD, S. M., WILSON, R. E., MAUNEY, M. A., LOCKHART, A. C., SMIALOWICZ, R. J., MOSER, V. C., BURKA, L. T. and COLLINS, B. J., 1997, The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function. Fundamental Applied Toxicology, 40, 138–157.
   PubMedGoogle Scholar
• CUMMINGS, A. M., 1997, Methoxychlor as a model for environmental estrogens [Review]. Critical Reviews of Toxicology, 27, 367–379.
   PubMed Web of Science ®Google Scholar
• CUMMINGS, A. M. and GRAY, JR, L. E., 1989, Antifertility effect of methoxychlor in female rats: dose-and time-dependent blockade of pregnancy. Toxicology and Applied Pharmacology, 97, 454–462.
   PubMedGoogle Scholar
• CUMMINGS, A. M. and LASKEY, J., 1993, Effect of methoxychlor on ovarian steroidogenesis: role in early pregnancy loss. Reproductive Toxicology, 7, 17–23.
   PubMed Web of Science ®Google Scholar
• DEHAL, S. S. and KUPFER, D., 1994, Metabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Dual pathways involving novel ortho ring-hydroxylation by CYP2B. Drug Metabolism and Disposition, 22, 937–946.
   PubMed Web of Science ®Google Scholar
• GAIDO, K. W., LEONARD, L. S., MANESS, S. C., HALL, J. M., MCDONNELL, D. P., SAVILLE, B. and SAFE, S., 1999, Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxypheny1)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology, 140, 5746–5753.
   PubMed Web of Science ®Google Scholar
• GAIDO, K. W., MANESS, S. C., MCDONNELL, D. P., DEHAL, S. S., KUPFER, D. and SAFE, S., 2000, Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure—activity studies. Molecular Pharmacology, 58, 852–858.
   PubMed Web of Science ®Google Scholar
• GARDNER, D. R. and BAILEY, J. R., 1975, Methoxychlor: Its Effects on Environmental Quality. No. 14102 (National Research Council of Canada NRC Association Committee on Scientific Criteria for Environmental Quality).
   Google Scholar
• GELBOIN, H. V., KRAUSZ, K. W., GONZALEZ, F. J. and YANG, T. J., 1999, Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery. Trends in Pharmacological Science, 20, 432–438.
   PubMed Web of Science ®Google Scholar
• GELBOIN, H. V., KRAUSZ, K. W., SHOU, M., GONZALEZ, F. J. and YANG, T. J., 1997, A monoclonal antibody inhibitory to human P450 2D6: a paradigm for use in combinatorial determination of individual P450 role in specific drug tissue metabolism. Pharmacogenetics, 7, 469–477.
   PubMedGoogle Scholar
• GOODWIN, B., REDINBO, M. R. and KLIEWER, S. A., 2002, Regulation of cyp3a gene transcription by the pregnane x receptor. Annual Review of Pharmacology and Toxicology, 42, 1–23.
   PubMed Web of Science ®Google Scholar
• GRAY, JR, L. E., OSTBY, J. S., FERRELL, J. M., SIGMON, E. R. and GOLDMAN, J. M., 1988, Methoxychlor induces estrogen-like alterations of behavior and the reproductive tract in the female rat and hamster: effects on sex behavior, running wheel activity and uterine morphology. Toxicology and Applied Pharmacology, 96, 525–540.
   Google Scholar
• Hu, Y. and KUPFER, D., 2002a, Metabolism of the endocrine disruptor pesticide methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metabolism and Disposition, 30, 1035–1042.
   PubMed Web of Science ®Google Scholar
• Hu, Y. and KUPFER, D., 2002b, Enantioselective metabolism of the endocrine disruptor pesticide methoxychlor by human cytochromes P450 (P450s): major differences in selective enantiomer formation by various P450 isoforms. Drug Metabolism and Disposition, 30, 1329–1336.
   PubMed Web of Science ®Google Scholar
• Hu, Y. and KUPFER, D., 2002c, Enantioselective metabolism of methoxychlor and its metabolites by human P450s. National Meeting of the International Society for Study of Xenobiotics (ISSX), Orlando, FL (2002). Proceedings in Drug Metabolism Reviews, 34\(Suppl. 1), 51 (abst 101).
   Google Scholar
• KISHIMOTO, D. and KURIHARA, N., 1996, Effects of cytochrome P450 antibodies on the oxidative demethylation of methoxychlor catalysed by rat liver cytochrome P450 isozymes: isozyme specificity and alteration of enantiotopic selectivity. Pesticide Biochemistry and Physiology, 56, 44–52.
   Google Scholar
• KISHIMOTO, D., OKu, A. and KURIHARA, N., 1995, Enantioselectivity of cytochrome P450-catalysed oxidative demethylation of methoxychlor — alteration of selectivity depending on isozymes and substrate concentration. Pesticide Biochemistry and Physiology, 51, 12–19.
   Google Scholar
• KRAUSZ, K. W., GOLDFARB, I., BUTERS, J. T. M., YANG, T. J., GONZALEZ, F. J. and GELBOIN, H. V., 2001, Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19. Drug Metabolism and Disposition, 29, 1410–1423.
   Google Scholar
• KUPFER, D. and BULGER, W. H., 1979, A novel in vitro method for demonstrating proestrogens. Metabolism of methoxychlor and o,p'-DDT by liver microsomes in the presence of uteri and effects of intracellular distribution of estrogen receptors. Life Sciences, 25, 975–984.
   PubMed Web of Science ®Google Scholar
• KUPFER, D., BULGER, W. H. and THEOHARIDES, A. D., 1990, Metabolism of methoxychlor by hepatic P-450 monooxygenases in rat and human. Characterization of a novel catechol metabolite. Chemical Research in Toxicology, 3, 8–16.
   PubMed Web of Science ®Google Scholar
• LEE, C. R., GOLDSTEIN, J. A. and PIEPER, J. A., 2002a, Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics, 12, 251–263; erratum 12, 343.
   Google Scholar
• LEE, C. R., PIEPER, J. A., HINDERLITER, A. L., BLAISDELL, J. A. and GOLDSTEIN, J. A., 2002b, Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes. Clinical Pharmacology and Therapeutics, 72, 562–571.
   PubMed Web of Science ®Google Scholar
• LEHMANN, J. M., MCKEE, D. D., WATSON, M. A., WILLSON, T. M., MOORE, J. T. and KLIEWER, S. A., 1998, The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation, 102, 1016–1023.
   PubMed Web of Science ®Google Scholar
• LI, H.-C., DEHAL, S. S. and KUPFER, D., 1995, Induction of the hepatic CYP2B and CYP3A enzymes by the proestrogenic pesticide methoxychlor and by DDT in the rat. Effects on methoxychlor metabolism. Journal of Biochemical and Molecular Toxicology, 10, 51–61.
   Web of Science ®Google Scholar
• Li, H.-C. and KUPFER, D., 1998, Mechanism of induction of rat hepatic CYP2B and 3A by the pesticide methoxychlor. Journal of Biochemical and Molecular Toxicology, 12, 315–323.
   Google Scholar
• METCALF, R. L., 1976, In The future of insecticides. R. L. Metcalf and J. J. McKelevey (eds) (New York: Wiley), pp. 223–285.
   Google Scholar
• METCALF, R. L., KAPooR, I. P. and HIRWE, A. S., 1971, Biodegradable analogues. Bulletin of WHO, 44, 363–377.
   PubMed Web of Science ®Google Scholar
• OUSTERHOUT, J. M., STRUCK, R. F. and NELSON, J. A., 1981, Estrogenic activities of methoxychlor metabolites. Biochemical Pharmacology, 30, 2869–2871.
   PubMed Web of Science ®Google Scholar
• SUEYOSHI, T., KAWAMOTO, T., ZELKO, I., HONKAKOSKI, P. and NEGISHI, M., 1999, The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. Journal of Biological Chemistry, 274, 6043–6046.
   PubMed Web of Science ®Google Scholar
• SUEYOSHI, T. and NEGISHI, M., 2001, Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annual Review of Pharmacology and Toxicology, 41, 123–143.
   PubMed Web of Science ®Google Scholar
• SUZUKI, H., KNELLER, B., HAINING, R. L., TRAGER, W. F. and RETTIE, A. E., 2002, (+)N-3-benzylnirvanol and (—)N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19. Drug Metabolism and Disposition, 30, 235–239.
   PubMed Web of Science ®Google Scholar
• VAN DER WEIDE, J., STEIJNS, L. S., VAN WEELDEN, M. J. and DE HAAN, K., 2001, The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement. Pharmacogenetics, 11, 287–289.
   PubMedGoogle Scholar
• WATERS, K. M., SAFE, S. and GAIDO, K. W., 2001, Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta and AR in reproductive tissues of female mice. Toxicological Sciences, 63, 47–56.
   PubMed Web of Science ®Google Scholar
• YANG, T. J., KRAUSZ, K. W., SAI, Y., GONZALEZ, F. J. and GELBOIN, H. V., 1999, Eight inhibitory monoclonal antibodies define the role of individual P450s in human liver microsomal diazepam, 7-ethoxycoumarin and imipramine metabolism. Drug Metabolism and Disposition, 27, 102–109.
   PubMed Web of Science ®Google Scholar
• You, L., CASANOVA, M., BARTOLUCCI, E. J., FRYCZYNSKI, M. W., DORMAN, D. C., EVERITT, J. I., GAIDO, K. W., Ross, S. M. and HECK, HD. H., 2002, Combined effects of dietary phytoestrogen and synthetic endocrine-active compound on reproductive development in Sprague—Dawley rats: genistein and methoxychlor. Toxicological Sciences, 66, 91–104.
   PubMed Web of Science ®Google Scholar